Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 4/29/202553 Original Research Drugs Approved in China in Early 2025
  • 4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
  • 4/29/2025Innovent Announces NMPA Approval of Limertinib
  • 4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...
  • 4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
  • 4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...
  • 4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020
  • 4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
  • 4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
  • 4/25/2025Akeso's Ivonescimab Gains Second Approval in China
  • 4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
  • 4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
  • 4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
  • 4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China
  • 4/22/2025China Approves New Indication of Opdivo for NSCLC
  • 4/22/2025Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance
  • 4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...
  • 4/22/2025Zai Lab's Repotrectinib sNDA Accepted by China NMPA
  • 4/22/2025Hengrui Initiates Phase I Trial for Novel Obesity siRNA Drug HRS-5817 ...
  • 4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
  • 4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
  • 4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
  • 4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing
  • 4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
  • 4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
  • 4/15/2025Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
  • 4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
  • 4/15/2025Gardasil9 Gains Expanded Approval in China
  • Page:1/12 Total number of articles:340: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group